VHPI: Vet-Harts Pilot Intervention for Veterans With Coronary Heart Disease
Study Details
Study Description
Brief Summary
The purpose of this research study is to survey patients to learn about their beliefs and behaviors related to the management of heart disease and to discuss options for making healthy lifestyle changes. From the information the investigators get from patients, the investigators hope to develop better methods for taking care of patients who have heart disease.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Detailed Description
Coronary heart disease (CHD) is a significant health threat among veterans. Compared to their civilian counterparts, veterans experience greater disability, reinfarction, and mortality following myocardial infarction (MI) and other acute coronary syndromes (ACS). High rates of hypertension, diabetes, and cardiac risk behaviors (e.g., smoking) and low socioeconomic status (SES) further increase veterans' CHD-related morbidity and mortality. The proposed pilot project will establish the feasibility of a telehealth nursing intervention for veterans with CHD who are recovering from MI/ACS. The Veterans Heart Attack Representations Telehealth (Vet-HART) intervention is designed to promote adaptive conceptual change in veterans' beliefs (common sense models or representations) about CHD etiology and self-management and facilitate health behavior changes (e.g., smoking cessation, medication adherence, diet management, and increased physical activity). The long-term goal of this research program is to improve veterans' quality of life (QoL) and reduce their CHD-related morbidity/mortality. The proposed project is the requisite next step in attaining that goal.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Motivational Interview For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. |
Behavioral: Motivational Interview
For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.
|
No Intervention: Usual Care For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Outcome Measures
Primary Outcome Measures
- SF-36v Physical Function Scale [Change from baseline to 3-months post hospital discharge]
Physical Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- SF-36v Role Limitations Due to Physical Health Scale [Change from baseline to 3-months post hospital discharge]
Role Limitations Due to Physical Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- SF-36v Role Limitations Due to Emotional Problems Scale [Change from baseline to 3-months post hospital discharge]
Role Limitations Due to Emotional Problems Scale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- SF-36v Energy-Fatigue Scale [Change from baseline to 3-months post hospital discharge]
Energy-Fatigue Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- SF-36v Emotional Well-Being Scale [Change from baseline to 3-months post hospital discharge]
Emotional Well-Being Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- SF-36v Social Functioning Scale [Change from baseline to 3-months post hospital discharge]
Social Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- SF-36v Pain Scale [Change from baseline to 3-months post hospital discharge]
Pain Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- SF-36v General Health Scale [Change from baseline to 3-months post hospital discharge]
General Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- Seattle Angina Questionnaire Physical Limitations Scale [Change from baseline to 3-months post hospital discharge]
Physical Limitations Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- Seattle Angina Questionnaire Angina Stability Scale [Change from baseline to 3-months post hospital discharge]
Angina Stability Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- Seattle Angina Questionnaire Angina Frequency Scale [Change from baseline to 3-months post hospital discharge]
Angina Frequency Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- Seattle Angina Questionnaire Treatment Satisfaction Scale [Change from baseline to 3-months post hospital discharge]
Treatment Satisfaction Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
- Seattle Angina Questionnaire Disease Perception Scale [Change from baseline to 3-months post hospital discharge]
Disease Perception Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Admission to an inpatient medicine unit for MI, ACS, and coronary angiography
-
Age
Exclusion Criteria:
-
Altered mental status
-
Language barriers
-
Dementia or Cognitive Impairment
-
Diagnostic Study
-
Resident in long-term care facility prior to the present admission
-
Planned discharge to a skilled or intermediate care facility or hospice
-
Lack of access to a functioning phone
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Iowa City VA Health Care System, Iowa City, IA | Iowa City | Iowa | United States | 52246-2208 |
Sponsors and Collaborators
- VA Office of Research and Development
- University of Iowa
Investigators
- Principal Investigator: Mark W Vander Weg, PhD MS BA, Iowa City VA Health Care System, Iowa City, IA
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PPO 09-283
- 200910778
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Period Title: Overall Study | ||
STARTED | 6 | 6 |
COMPLETED | 3 | 6 |
NOT COMPLETED | 3 | 0 |
Baseline Characteristics
Arm/Group Title | Motivational Interview | Usual Care | Total |
---|---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. | Total of all reporting groups |
Overall Participants | 6 | 6 | 12 |
Age (Years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [Years] |
68.33
(11.98)
|
65.67
(8.64)
|
67.00
(10.05)
|
Sex: Female, Male (Count of Participants) | |||
Female |
0
0%
|
0
0%
|
0
0%
|
Male |
6
100%
|
6
100%
|
12
100%
|
Race (NIH/OMB) (Count of Participants) | |||
American Indian or Alaska Native |
0
0%
|
0
0%
|
0
0%
|
Asian |
0
0%
|
0
0%
|
0
0%
|
Native Hawaiian or Other Pacific Islander |
0
0%
|
0
0%
|
0
0%
|
Black or African American |
0
0%
|
0
0%
|
0
0%
|
White |
3
50%
|
1
16.7%
|
4
33.3%
|
More than one race |
0
0%
|
0
0%
|
0
0%
|
Unknown or Not Reported |
3
50%
|
5
83.3%
|
8
66.7%
|
Region of Enrollment (participants) [Number] | |||
United States |
6
100%
|
6
100%
|
12
100%
|
Outcome Measures
Title | SF-36v Physical Function Scale |
---|---|
Description | Physical Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
Participants who completed the SF-36v at baseline, 1 month, and 3 months. |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-6.67
(7.64)
|
13.33
(12.52)
|
Title | SF-36v Role Limitations Due to Physical Health Scale |
---|---|
Description | Role Limitations Due to Physical Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-22.92
(35.54)
|
9.38
(36.39)
|
Title | SF-36v Role Limitations Due to Emotional Problems Scale |
---|---|
Description | Role Limitations Due to Emotional Problems Scale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-27.78
(25.46)
|
5.56
(13.61)
|
Title | SF-36v Energy-Fatigue Scale |
---|---|
Description | Energy-Fatigue Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-5.00
(42.65)
|
1.67
(23.49)
|
Title | SF-36v Emotional Well-Being Scale |
---|---|
Description | Emotional Well-Being Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-14.67
(37.86)
|
-2.00
(7.90)
|
Title | SF-36v Social Functioning Scale |
---|---|
Description | Social Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-16.67
(40.18)
|
-10.42
(18.40)
|
Title | SF-36v Pain Scale |
---|---|
Description | Pain Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-5.00
(13.23)
|
14.17
(13.10)
|
Title | SF-36v General Health Scale |
---|---|
Description | General Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-5.00
(18.03)
|
4.17
(17.15)
|
Title | Seattle Angina Questionnaire Physical Limitations Scale |
---|---|
Description | Physical Limitations Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-5.93
(8.98)
|
3.33
(30.43)
|
Title | Seattle Angina Questionnaire Angina Stability Scale |
---|---|
Description | Angina Stability Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
Note that because 4 participants in the Usual Care group reported that they did not experience chest pain in the prior four weeks, their responses could not be included in the analysis, as the scale measures changes in the severity of chest pain. Therefore, only 2 participants in the Usual Care group contributed to the analysis. |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 2 |
Mean (Standard Deviation) [units on a scale] |
25.00
(66.14)
|
-12.50
(17.68)
|
Title | Seattle Angina Questionnaire Angina Frequency Scale |
---|---|
Description | Angina Frequency Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
20.00
(43.59)
|
16.67
(22.51)
|
Title | Seattle Angina Questionnaire Treatment Satisfaction Scale |
---|---|
Description | Treatment Satisfaction Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
-3.92
(33.45)
|
7.84
(10.95)
|
Title | Seattle Angina Questionnaire Disease Perception Scale |
---|---|
Description | Disease Perception Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning. |
Time Frame | Change from baseline to 3-months post hospital discharge |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Motivational Interview | Usual Care |
---|---|---|
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. |
Measure Participants | 3 | 6 |
Mean (Standard Deviation) [units on a scale] |
13.89
(9.62)
|
9.72
(17.01)
|
Adverse Events
Time Frame | 3 Months | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Motivational Interview | Usual Care | ||
Arm/Group Description | For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. | For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. | ||
All Cause Mortality |
||||
Motivational Interview | Usual Care | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/6 (0%) | 0/6 (0%) | ||
Serious Adverse Events |
||||
Motivational Interview | Usual Care | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/6 (0%) | 0/6 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Motivational Interview | Usual Care | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/6 (0%) | 0/6 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Mark Vander Weg |
---|---|
Organization | Iowa City VA Health Care System |
Phone | 319-338-0581 ext 7717 |
mark.vanderweg@va.gov |
- PPO 09-283
- 200910778